Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

SELL
$247.06 - $1507.4 $217,165 - $1.33 Million
-879 Reduced 1.47%
59,001 $15.2 Million
Q2 2022

Aug 10, 2022

SELL
$237.11 - $299.66 $124,482 - $157,321
-525 Reduced 0.87%
59,880 $15.2 Million
Q1 2022

May 13, 2022

BUY
$257.27 - $315.76 $8,747 - $10,735
34 Added 0.06%
60,405 $17.7 Million
Q4 2021

Feb 22, 2022

BUY
$292.08 - $329.01 $457,689 - $515,558
1,567 Added 2.66%
60,371 $19.9 Million
Q2 2021

Aug 12, 2021

SELL
$225.08 - $271.69 $109,163 - $131,769
-485 Reduced 0.82%
58,804 $15.8 Million
Q1 2021

May 12, 2021

SELL
$212.38 - $245.9 $3.23 Million - $3.74 Million
-15,195 Reduced 20.4%
59,289 $13.3 Million
Q4 2020

Feb 08, 2021

SELL
$212.5 - $245.46 $172,125 - $198,822
-810 Reduced 1.08%
74,484 $16.5 Million
Q3 2020

Nov 12, 2020

SELL
$177.16 - $215.33 $59,880 - $72,781
-338 Reduced 0.45%
75,294 $16.2 Million
Q2 2020

Aug 13, 2020

SELL
$128.7 - $176.83 $109,394 - $150,305
-850 Reduced 1.11%
75,632 $13.4 Million
Q1 2020

Apr 24, 2020

BUY
$121.39 - $169.05 $27,312 - $38,036
225 Added 0.3%
76,482 $10.6 Million
Q4 2019

Feb 14, 2020

SELL
$133.47 - $153.48 $130,533 - $150,103
-978 Reduced 1.27%
76,257 $11.7 Million
Q3 2019

Nov 01, 2019

BUY
$135.4 - $146.47 $10.5 Million - $11.3 Million
77,235 New
77,235 $11.2 Million
Q2 2019

Aug 05, 2019

SELL
$124.88 - $143.73 $9.48 Million - $10.9 Million
-75,880 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$124.88 - $143.73 $299,712 - $344,952
2,400 Added 3.27%
75,880 $10.8 Million
Q1 2019

May 06, 2019

BUY
$97.62 - $132.29 $3.49 Million - $4.73 Million
35,780 Added 94.91%
73,480 $9.7 Million
Q4 2018

Feb 05, 2019

SELL
$94.85 - $109.54 $12,330 - $14,240
-130 Reduced 0.34%
37,700 $3.89 Million
Q3 2018

Nov 09, 2018

BUY
$98.13 - $108.9 $3.71 Million - $4.12 Million
37,830 New
37,830 $4.11 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $174B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Cypress Capital Management LLC Portfolio

Follow Cypress Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Management LLC with notifications on news.